The market's having a good day, so why's the Ramsay Health Care (ASX:RHC) share price struggling?

What's weighing on Ramsay's stock today?

| More on:
A doctor in a white coat with a stethoscope around her neck holds her hands upwards as if to ask 'why' as she sits at her desk and looks at her computer.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Ramsay Health Care Limited (ASX: RHC) share price is pushing through a turbulent day on the ASX, despite the wider market's day in the sun.

Right now, the S&P/ASX 200 Index (ASX: XJO) has gained 1.07% or 77.9 points. Meanwhile, the All Ordinaries Index (ASX: XAO) is 1.15% higher having increased by 87.7 points today.

On the other hand, the Ramsay Health Care share price has been seesawing today. It has recorded an intraday high of $70.19 and a low of $69.09.

At the time of writing, it's down 0.24%, with shares in the company trading for $69.58 a piece.

So what's weighing on the Ramsay Health Care share price? Let's take a look.

What's up with Ramsay's stock today?

The Ramsay Health Care share price is struggling on what is a fantastic day for the broader market.

Interestingly, there hasn't been any happenings to explain the healthcare company's tough day's trade.

In fact, the market hasn't heard price-sensitive news from Ramsay since it released its earnings for financial year 2021 nearly a month ago.

However, Ramsay's stock isn't alone in its struggles. The S&P/ASX 200 Health Care Index (ASX: XHJ) is the worst performing sector of the ASX 200 today.

It has fallen 0.09%, or 46.3 points, at the time of writing, with Ramsay being one of its worst performing stocks.

Only Ansell Limited (ASX: ANN) is weighing on the sector more than Ramsay. It has currently fallen 1% to trade at $34.69.

Meanwhile, the Clinuvel Pharmaceuticals Limited (ASX: CUV) share price is leading the sector with a 4.4% gain.

Ramsay Health Care share price snapshot

Despite today's dip, the Ramsay Health Care share price has been performing alright lately.

It has gained 11% since the start of 2021. It is also 0.2% higher than it was this time last year.

Motley Fool contributor Brooke Cooper has no position in any of the stocks mentioned.

The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Ansell Ltd. and Ramsay Health Care Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Healthcare Shares

Healthcare Shares

Guess which ASX small cap stock is jumping on 'significant milestone'

This stock is ending the week in style. Let's see what is giving its shares a boost today.

Read more »

Healthcare Shares

Are CSL and this ASX 200 healthcare stock buys in January?

Is now a good time to pick up these shares? Let's see what analysts are saying.

Read more »

A woman presenting company news to investors looks back at the camera and smiles.
Communication Shares

2 ASX shares expected to report strong earnings this quarter

Analysts expect a strong set of upcoming numbers for these ASX heavyweights

Read more »

A women has her eyes checked at the optometrist.
Healthcare Shares

Is Medibank stock a good buy?

Can this company provide healthy returns?

Read more »

A woman jumps for joy with a rocket drawn on the wall behind her.
Healthcare Shares

Guess which ASX healthcare stock is jumping 7% on US FDA approval news

This share is giving its shareholders an early Christmas present.

Read more »

A senior pharmacist talks to a customer at the counter in a shop
Healthcare Shares

Is it too late to buy Sigma shares to cash in on the Chemist Warehouse deal?

Can investors still make healthy returns with this stock?

Read more »

Shot of a scientist using a computer while conducting research in a laboratory.
Healthcare Shares

Why the Mesoblast share price is diving 18% after an FDA win

Investors are sending the Mesoblast share price tumbling on Friday. But why?

Read more »

A happy doctor in a white coat dancing due to his excitement over the EBOS acquisition
Healthcare Shares

Mesoblast share price rockets 30% on big US FDA news

Big news is giving this biotech a huge lift on Thursday.

Read more »